This page lists the SEC filings reported by REGENTS OF THE UNIVERSITY OF CALIFORNIA.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-01-24 | - | - | - | - | EDGAR |
| SC 13G/A | 2024-01-24 | - | - | - | - | EDGAR |
| SC 13G/A | 2024-01-24 | - | - | - | - | EDGAR |
| SC 13G/A | 2024-01-24 | - | - | - | - | EDGAR |
| SC 13G/A | 2024-01-24 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Surrozen, Inc. | 138,764 | 6.8% | EDGAR |
| SC 13G | 2024-01-24 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Blackstone Real Estate Income Trust, Inc. | 302,775,462 | 7.4% | EDGAR |
| SC 13G | 2023-07-03 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Lafayette Square USA, Inc. | 2,338,057 | 17.9% | EDGAR |
| SC 13G/A | 2023-02-02 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Technology Finance Corp. | 25,239,104 | 12.5% | EDGAR |
| SC 13G/A | 2023-02-02 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Surrozen, Inc./DE | 2,081,453 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-02 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Technology Finance Corp. II | 12,031,404 | 14.2% | EDGAR |
| SC 13G/A | 2023-02-02 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Capital Corp | 27,024,369 | 6.9% | EDGAR |
| SC 13G | 2022-10-28 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Technology Finance Corp. II | 4,664,139 | 21.1% | EDGAR |
| SC 13G | 2022-10-28 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Technology Finance Corp. | 25,239,104 | 12.6% | EDGAR |
| SC 13G/A | 2022-01-27 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Surrozen, Inc./DE | 2,081,453 | 5.9% | EDGAR |
| SC 13G | 2022-01-27 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Capital Corp | 32,157,815 | 8.2% | EDGAR |
| SC 13G | 2021-02-01 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | Owl Rock Capital Corp | 42,690,843 | 11.0% | EDGAR |
| SC 13G | 2021-02-01 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | RAPT Therapeutics, Inc. | 1,122,237 | 4.5% | EDGAR |
| SC 13G | 2021-02-01 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | CONSTELLATION PHARMACEUTICALS INC | 737,406 | 1.5% | EDGAR |
| SC 13G | 2020-02-24 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | RAPT Therapeutics, Inc. | 1,342,237,000 | 6.1% | EDGAR |
| SC 13G | 2020-02-14 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | CONSTELLATION PHARMACEUTICALS INC | 1,747,406,000 | 5.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.